Trials / Not Yet Recruiting
Not Yet RecruitingNCT07249606
Momelotinib Effectiveness in Myelofibrosis
Real-world Observation of Momelotinib Effectiveness in Myelofibrosis (ROME)
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (estimated)
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational study aimed at evaluating the use of momelotinib in patients with primary or post polycythemia vera (PV) or post essential thrombocythemia myelofibrosis (post-ET MF) in a real-world setting.
Detailed description
This is a multicenter prospective and retrospective observational clinical study in adult patients with primary or post polycythemia vera (PV) or post essential thrombocythemia myelofibrosis (post-ET MF) being treated with momelotinib in a real-world setting. The aim of the study is to evaluate the efficacy of momelotinib in terms of splenic response. All patients are managed according to the clinical practice of the participating Center.
Conditions
Timeline
- Start date
- 2026-01-02
- Primary completion
- 2028-01-02
- Completion
- 2028-04-02
- First posted
- 2025-11-25
- Last updated
- 2025-11-25
Source: ClinicalTrials.gov record NCT07249606. Inclusion in this directory is not an endorsement.